Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1983 studies found for:    HIV [CONDITION] AND NIH [SPONSOR-COLLABORATORS-CLASS] NOT NIMH [ORGANIZATION-NAME]
Show Display Options
Rank Status Study
21 Completed
Has Results
Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth
Conditions: HIV Infection;   Hepatitis B
Interventions: Biological: Engerix-B 20 mcg;   Biological: Engerix-B 40 mcg;   Biological: Twinrix 720 EIA HAV Ag plus 20 mcg HBsAg
22 Completed Typology of Adherence in Adolescents: Phase II
Condition: HIV Infection
Intervention:
23 Unknown  Engaging Care for HIV-Infected Adolescent Females.
Condition: HIV Infection
Intervention:
24 Completed PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir
Condition: HIV Infections
Intervention: Procedure: blood draw
25 Completed Safety and Acceptability of PRO 2000 Vaginal Gel in HIV Uninfected Women in India
Condition: HIV Infections
Intervention: Drug: PRO 2000/5 Gel (P)
26 Completed HIV Prevention Preparedness Study in Russia, China, and India
Condition: HIV Infections
Intervention:
27 Completed A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk Contacts
Condition: HIV Infections
Intervention: Behavioral: Peer HIV Education Program
28 Completed Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies
Condition: HIV Infections
Intervention: Drug: Tenofovir disoproxil fumarate
29 Completed
Has Results
Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Nevirapine placebo
30 Completed BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women
Condition: HIV Infections
Interventions: Drug: BufferGel;   Drug: PRO 2000/5 Gel;   Drug: Placebo gel
31 Completed Safety and Acceptability of a Vaginal Microbicide
Conditions: HIV Infections;   Hepatitis B, Chronic
Intervention: Drug: 1% tenofovir gel
32 Terminated Development of a Life Skills Intervention for Young Adolescents Perinatally-Infected With HIV and Their Caregivers
Condition: HIV Infection
Intervention:
33 Completed Microbicides Acceptability Among Sexually Active Young Women
Condition: HIV Infections
Intervention: Behavioral: Automated diary system
34 Completed HIV Treatment-Readiness Measure (HTRM) Validation
Condition: HIV Infections
Intervention:
35 Recruiting Enhancement of Connect to Protect® (C2P)
Condition: HIV Infection
Intervention: Behavioral: Community Mobilization
36 Completed Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission
Condition: HIV Infections
Interventions: Drug: Erythromycin;   Drug: Nevirapine;   Drug: Ampicillin sodium;   Drug: Metronidazole
37 Completed Immunologic Memory (Supp. of ATN 024)
Condition: HIV Infections
Interventions: Biological: Engerix B;   Biological: Twinrix for ATN 024;   Biological: Recombivax;   Biological: Twinrix for ATN 025
38 Completed Identifying Undiagnosed Asymptomatic HIV Infection in Hispanic/Latino Adolescents and Young Adults
Condition: HIV
Intervention: Behavioral: Effectiveness of different strategies in HIV testing and linkage to care
39 Completed C2P - Phase III: MPowerment and Community Promise
Condition: HIV Infections
Interventions: Behavioral: Printed materials;   Behavioral: Peer advocates
40 Withdrawn Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected Adolescents
Condition: HIV Infection
Interventions: Dietary Supplement: Probiotics;   Dietary Supplement: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years